author-photo

Charles D. Blanke

Oregon Health & Science University
University of British Columbia
Vanderbilt University

333

Papers

23596

Citations

Citation Trend

Filter By

Papers (333) Sort By

Journal Conference Others

Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.

2021 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (1)
1503O Clinical and scientific impact of National Cancer Institute: Sponsored clinical trial network group treatment trials

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931).

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Does adjuvant chemoradiation benefit patients with lymph node-positive biliary tract cancer? A secondary analysis of SWOG S0809.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic.

2021
Show All
- Source
- Cite
- Save
Citations (2)
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.

2021 JAMA
Show All
- Source
- Cite
- Save
Citations (5)
Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.

2021 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (0)
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆.

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)